Colorectal cancer: a multipathway disease

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The Vogelstein model simplifies colorectal tumorigenesis as a linear sequence of genetic alterations.
• Colorectal cancer (CRC) is increasingly recognized as a complex, multi-pathway disease.
• The role of Adenomatous Polyposis Coli (APC) gene inactivation in initiating CRC is a key area of study.

Purpose of the Study:

• To review the multi-pathway nature of colorectal cancer development.
• To challenge the oversimplification of APC inactivation as the sole initiator of CRC.
• To highlight alternative initiating events and their molecular context in CRC.

Main Methods:

• Literature review of colorectal cancer research.
• Analysis of genetic alterations and signaling pathways involved in tumorigenesis.
• Examination of molecular features across different CRC subgroups.

Main Results:

• APC inactivation is not the only initiating event in colorectal cancer.
• Alternative initiating steps, such as BRAF and KRAS mutations, synergize with DNA methylation.
• These alternative pathways are often associated with serrated polyps.
• APC inactivation may have roles beyond initial tumorigenesis.

Conclusions:

• Colorectal cancer development is more complex than the linear Vogelstein model suggests.
• Multiple distinct pathways contribute to CRC initiation and progression.
• Understanding these diverse pathways is crucial for classifying CRC subgroups and developing targeted therapies.